Fisher, B., Szántó, A., Ng, W., Bombardieri, M., Posch, M., Papas, A., Farag, A., Daikeler, T., Bannert, B., Kyburz, D., Kivitz, A., Carsons, S., Isenberg, D., Barone, F., Bowman, S., Espié, P., Floch, D., Dupuy, C., Ren, X., Faerber, P., Wright, A., Hockey, H., Rotte, M., Milojevic, J., Avrameas, A., Valentin, M., Rush, J.,
Gergely, P.:
Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study.
The Lancet Rheumatology. 2 (3), 142-152, 2020.
Folyóirat-mutatók:
Q2 Immunology
Q1 Immunology and Allergy
Q1 Rheumatology